Pediatric liver transplantation has experienced improved outcomes over the last 50 years.
This can be attributed in part to establishing optimal use of immunosuppressive agents to …

A number of medications do not have a licence, or label, for use in the paediatric age group
nor for the specific indication for which they are being used in children. Over recent years …

OBJECTIVES: Mycophenolic acid (MPA) is the active form of mycophenolate mofetil (MMF),
which is currently used off-label as immunosuppressive therapy in childhood-onset SLE …

In the last 25 years, liver transplantation in children has become an effective, definitive, and
universally accepted treatment for terminal liver diseases. Long-term survival exceeds 80 …

Cardiovascular (CV) events account for 8%‐13% of deaths after liver transplantation (LT) in
adulthood. Although CV risk factors (RFs) are present, little is known about the prevalence of …

The outcome of liver transplantation is usually reported in terms of graft and patient survival,
medical and surgical complications, and quality of life, but when it comes to transplanted …

Liver transplantation is the definitive treatment for end‐stage liver disease in both children
and adults. Advances over the last 2 decades have resulted in excellent patient and graft …

Renal dysfunction in the perioperative liver transplant peri... : Current Opinion in Organ
Transplantation Renal dysfunction in the perioperative liver transplant period : Current Opinion …

Background Introduction of calcineurin-inhibitor (CNI) has made transplantation a miracle in
the past century. However, the side effects of long-term use of CNI turn out to be one of the …

Mycophenolate mofetil (MMF) in combination with calcineurin inhibitors (CNIs) has greatly
contributed to acute rejection rate reduction. Because of its immunosuppressive potency it …